Key result
In obese-diabetic female rats, 17β-estradiol supplementation following ovariectomy worsened glycemic control, increased dyslipidemia, and promoted a maladaptive hypertrophic expansion of visceral adipose tissue.
Why the study?
The role of 17β-estradiol in obesity and diabetes is uncertain, with evidence questioning its cardioprotective effects in this context.
Should not yet alter hormone therapy in diabetic women; hypothesis-generating for context-specific estrogen effects in metabolic disease.
It has been reported that 17β-estradiol (E2) can exert beneficial effects against the development of obesity, providing women with a healthier metabolic profile and conferring cardiovascular protection. However, a growing body of evidence questions this role in the context of obesity and diabetes. We focus on the adipose tissue-heart axis to address the question of whether E2 can have metabolically detrimental effects in an obese-diabetic rat model. Female Zucker Diabetic Fatty rats were used: LEAN, fa/+; SHAM, sham-operated fa/fa; OVA, ovariectomized fa/fa, and OVA+E2, ovariectomized and E2 treated fa/fa. The secretory expression profile, tissue expansion parameters and composition of visceral adipose tissue, as well as systemic and cardiac parameters related to insulin resistance, fibrosis, and inflammation were analyzed. Ovariectomy induced an attenuation of both diabetic condition and metabolic dysfunction of adipose tissue and cardiac muscle in fa/fa rats, suggesting that E2, in the context of diabetes and obesity, loses its cardioprotective role and could even contribute to greater metabolic alterations. Adipose tissue from OVA rats showed a healthier hyperplastic expansion pattern, which could help maintain tissue function, increase adiponectin expression, and decrease pro-inflammatory adipokines. These findings should be taken into account when considering hormone replacement therapy for obese-diabetic women.
No takes yet. Share an insight, caveat, or question.
Martínez-Cignoni et al. (2021) studied Obesity and Type 2 Diabetes (n=32). 17β-estradiol (E2) vs. Ovariectomy without E2 replacement (OVA) and Sham-operated (SHAM) was evaluated. In obese-diabetic female rats, 17β-estradiol supplementation following ovariectomy worsened glycemic control, increased dyslipidemia, and promoted a maladaptive hypertrophic expansion of visceral adipose tissue.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: